Overview

To Evaluate the Response to Glucagon During Hypoglycemia

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the response to Glucagon versus the spontaneous hormonal response to low blood sugar levels in T2DM Patients treated with AZD1656 and Metformin
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Glucagon
Glucagon-Like Peptide 1